<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent work has established that heterozygous germline GATA2 mutations predispose carriers to familial <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>)/<z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), "MonoMAC" syndrome, and DCML deficiency </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we describe a previously unreported <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> family carrying a missense GATA2 mutation (p.Thr354Met), one patient with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> carrying a frameshift GATA2 mutation (p.Leu332Thrfs*53), another with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> harboring a GATA2 splice site mutation, and 3 patients exhibiting <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> who have large deletions encompassing the GATA2 locus </plain></SENT>
<SENT sid="2" pm="."><plain>Intriguingly, 2 MDS/AML or "MonoMAC" syndrome patients with GATA2 deletions and one with a frameshift mutation also have primary <z:hpo ids='HP_0001004'>lymphedema</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Primary <z:hpo ids='HP_0001004'>lymphedema</z:hpo> occurs as a result of aberrations in the development and/or function of lymphatic vessels, spurring us to investigate whether GATA2 plays a role in the lymphatic vasculature </plain></SENT>
<SENT sid="4" pm="."><plain>We demonstrate here that GATA2 protein is present at high levels in lymphatic vessel valves and that GATA2 controls the expression of genes important for programming lymphatic valve development </plain></SENT>
<SENT sid="5" pm="."><plain>Our data expand the phenotypes associated with germline GATA2 mutations to include predisposition to primary <z:hpo ids='HP_0001004'>lymphedema</z:hpo> and suggest that complete haploinsufficiency or loss of function of GATA2, rather than missense mutations, is the key predisposing factor for <z:hpo ids='HP_0001004'>lymphedema</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, we reveal a crucial role for GATA2 in lymphatic vascular development </plain></SENT>
</text></document>